Company profile
Veltex Corporation
OTC: VLXC · Healthcare · Medical - Care Facilities
#805 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
50DFH 43DQ —GM 60SS 70
v0.1 · 45/100 weight · provisional
↑ 3-yr revenue growth, workforce scale · ↓ growth stability, balance-sheet leverage
Methodology →Revenue TTM
$1.7M
Rev growth YoY (TTM)
-3.5%
Net income (FY)
-$1.3M
Employees
1,200
as of 2026-08-24
Market cap
$3.9M
as of 2026-08-24
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.9M$1.9M2025
Net income-$1.3M-$1.3M2025
Operating income-$1.5M-$1.5M2025
Total assets$1.8M$1.8M2025
Liabilities$4.7M$4.7M2025
Equity-$2.9M-$2.9M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Veltex Corporation’s revenue?
Veltex Corporation booked $1.9M in FY2025 revenue, growing 38% year over year — faster than most Healthcare companies we track, at a -68.4% net margin.
Peers · Healthcare
iSpecimen Inc.29DAnteris Technologies Global Corp.32DLongevity Health Holdings Inc.22DBio Essence Corporation52DResonate Blends, Inc.——Vycor Medical, Inc.56CNeighbors
Cook →Key facts
CEOAndreas Mauritzson
SectorHealthcare
IndustryMedical - Care Facilities
HeadquartersChicago, IL
ExchangeOTC: VLXC
Employees1,200
IPO date2001-07-18
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.